Patent Assignment
Reel/Frame 027715/0552
Change of Name
Recorded: 2012-02-16
Pages: 4
Assignor
CARIDIANBCT BIOTECHNOLOGIES, LLC.
Executed: 2012-01-04
Assignee
TERUMO BCT BIOTECHNOLOGIES, LLC
1215 QUAIL STREET, MAIL STOP: 8101F2, LAKEWOOD, COLORADO, 80215
Covered Properties
(30)
Method and Apparatus for Inactivation of Biological Contaminants Using Endogenous Alloxazine or Isoalloxazine Photosensitizers
Patent:
6,258,577 →
Application:
09/119,666 →
Method and Apparatus for Inactivation of Biological Contaminants Using Photosensitizers
Patent:
6,277,337 →
Application:
09/357,188 →
Isoalloxazine Derivatives to Neutralize Biological Contaminants
Patent:
6,268,120 →
Application:
09/420,652 →
Method and Apparatus for Inactivation of Biological Contaminants Using Photosensitizers
Patent:
7,094,378 →
Application:
09/596,429 →
Storage Solution Containing Photosensitizer for Inactivation of Biological Contaminants
Patent:
6,548,241 →
Application:
09/725,426 →
Isoalloxazine Derivatives to Neutralize Biological Contaminants
Preparation of Vaccines Using a Photosensitizer and Light
Reduction of Contaminants in Blood and Blood Products Using Photosensitizers and Peak Wavelengths of Light
Inactivation of West Nile Virus and Malaria Using Photosensitizers
Method and apparatus for inactivation of biological contaminants using photosensitizers
Application:
10/377,524 →
Publication:
US 2003/0215784
Removal of Adenine During a Pathogen Reduction Process in Whole Blood or Red Cells by Dilution
Method for Preventing Damage to or Rejuvenating a Cellular Blood Component Using Mitochondrial Enhancer
Induction of and Maintenance of Nucleic Acid Damage in Pathogens Using Riboflavin and Light
Methods for Uniformly Treating Biological Samples with Electromagnetic Radiation
Methods for Reducing Pathogens in Biological Samples
Application:
11/428,669 →
Publication:
US 2007/0009377
Preventing Transfusion Related Complications in a Recipient of a Blood Transfusion
Methods and Compositions for the Production of High Concentration Alloxazine Solutions
Reduction of Contaminants in Blood and Blood Products Using Photosensitizers and Peak Wavelengths of Light
Methods for Washing a Red Blood Cell Component and for Removing Prions Therefrom
Induction of and Maintenance of Nucleic Acid Damage in Pathogens Using Riboflavin and Light
Apparatus and Method for Separating Volumes of a Composite Liquid with a Balancing Assembly
Apparatus for Photo Reduction of Contaminants in Blood and Blood Products with Calibration Means
Pathogen Inactivation of Whole Blood
Application:
12/182,280 →
Publication:
US 2008/0299538
Clamp Assembly for Displacing Fluid from Portions of Fluid Containers
Preventing Transfusion Related Complications in a Recipient of a Blood Transfusion
Removal of Adenine During a Pathogen Reduction Process in Whole Blood or Red Blood Cells by Dilution
Preparation of Vaccines Using Photosensitizer and Light
Apparatus for Photo Reduction of Contaminants in Blood and Blood Products with Calibration Means
Induction of and Maintenance of Nucleic Acid Damage in Pathogens Using Riboflavin and Light
Methods and Compositions for the Production of High Concentration Alloxazine Solutions
Application:
13/216,859 →
Publication:
US 2011/0306617
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Apr 28, 2011
From: CITICORP TRUSTEE COMPANY LIMITED, AS SECURITY AGENT
To: CARIDIANBCT BIOTECHNOLOGIES, LLC
Reel/Frame 026192/0547 →
Release of Security Interest
Apr 28, 2011
From: CITICORP TRUSTEE COMPANY LIMITED, AS SECURITY AGENT
To: GAMBRO, INC.
Reel/Frame 026209/0914 →
Release of Security Interest
Aug 11, 2011
From: CITICORP TRUSTEE COMPANY LIMITED, AS SECUIRTY AGENT
To: CARIDIANBCT BIOTECHNOLOGIES, LLC
Reel/Frame 026737/0537 →